What to Look at When Comparing Protein A Resins

Comparison Requires Matched Conditions

Protein A affinity chromatography is the standard for the monoclonal antibody capture step, but the high price of the resin and its limited lifetime continue to be cited as challenges.[7][13] Published binding capacities were obtained with different antibodies and residence times, so placing the numbers side by side does not make a comparison.[1][5]

Dynamic Binding Capacity

Dynamic binding capacity (DBC) is the amount of antibody the resin captures under actual flow conditions. This value depends strongly on residence time, and it also varies with the type of antibody and the resin.[1][2] It is usually calculated as the amount loaded up to the point at which the UV signal of the effluent reaches 10% of its maximum (10% breakthrough).[4][5] Therefore, compare values that share the same residence time and breakthrough criterion and, where possible, were measured with your own feed.

Base Matrix and Particle Size

Base matrices are divided into glass/silica-based, agarose-based and synthetic polymer-based types.[1] In a study comparing 15 commercially available resins, the dependence on residence time differed by base matrix, and the difference was explained by particle diameter and mass transfer rate.[2] Particle size and compressibility affect bed height design, so check the pressure-flow characteristics as well.[1][6]

Cleaning Resistance and Lifetime

Sodium hydroxide (NaOH) is used for cleaning-in-place (CIP). According to review articles, agarose-based and polymer-based resins can be sanitized with dilute NaOH (0.05~0.2 N, 30 min contact), and alkali-stabilized ligands withstand 0.1~0.5 N.[1][7] The number of reuse cycles is reported as 100~200 or more,[1][7] but with repeated use the ligand degrades and is lost, and binding capacity declines.[4][7] Lifetime is affected by the cleaning solution and the feed, so it is established by repeated cycling tests with the actual feed.[1][7]

Impurities and Elution Conditions

• Leached Protein A: the ligand elutes together with the antibody; it is classified as a process-related impurity.[8][15] It is measured by enzyme-linked immunosorbent assay (ELISA),[8][9] and removed in the subsequent ion exchange step.[1][8]
• Elution pH: elution requires a low pH (2.5~4), and this condition can cause antibody aggregation.[1][10] Look at the elution pH and the aggregate percentage for each resin together.[1][6]
• Host cell protein (HCP): a substantial portion is removed in the Protein A step, but the residual amount varies with the resin, the feed and the wash conditions.[1][11] There are reports that the differences between resins were large and reports that they were small.[3][6]

Cost and Regulatory Documents

It is reasonable to assess resin cost not by price per liter but by cost per g of antibody, which reflects binding capacity, number of reuse cycles and number of batches per year.[7][12]

Check whether the supplier has a regulatory support file and, if you are preparing for approval in the United States, whether you can obtain a letter of authorization to reference its Drug Master File (DMF).[17][18] Changing the resin material after approval constitutes a change to the purification process.[14][16] ICH Q5E (2004 Step 4, current) takes the view that the pre-change and post-change products do not need to be identical but must be highly similar, and calls for this to be shown through analysis of quality attributes, impurity removal capability, process controls and stability data.[14][19]

Sources